Viewing Study NCT01286103


Ignite Creation Date: 2025-12-24 @ 7:30 PM
Ignite Modification Date: 2026-03-15 @ 8:06 PM
Study NCT ID: NCT01286103
Status: COMPLETED
Last Update Posted: 2012-03-13
First Post: 2011-01-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Pharmacokinetic and Pharmacodynamic Study of Once-Daily and Twice-Daily Dosing With Canagliflozin in Healthy Adult Volunteers
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Canagliflozin View
None Pharmacokinetics View
None Pharmacodynamics View